Eli Lilly Message Board - Msg: 32789293

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly

LLY 1,057

+1.5%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Moonray	6/15/2020 10:33:26 PM
	of 642

Covid Report: Eli Lilly Says Its Arthritis Drug Could Tackle Coronavirus Pharmaceutical giant Eli Lilly ( LLY) said Monday it's beginning a Phase 3 study of its rheumatoid arthritis drug, Olumiant, in coronavirus treatment. Lilly just enrolled the first out of 400 patients planned for the study. The pharma company will test Olumiant as a coronavirus treatment in hospitalized patients. Patients must have at least one marker of inflammation but don't need mechanical ventilation. Researchers will test whether Olumiant — an anti-inflammatory treatment — can reduce heightened immune responses in patients with Covid-19. These immune responses, known as cytokine storms, cause the body to attack itself. More at: investors.com o~~~ O

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next